Digital interventions improve adherence to oral pre-exposure prophylaxis for human immunodeficiency virus prevention across early treatment phases, according to findings from a systematic review and meta-analysis published in BMC Public Health. Oral pre-exposure prophylaxis substantially lowers human immunodeficiency virus acquisition risk, yet practical effectiveness remains constrained by inadequate uptake and suboptimal compliance. To evaluate whether digital technologies help mitigate these implementation barriers, researchers examined randomized controlled trials evaluating digital solutions designed to support oral prophylaxis engagement.
The quantitative evaluation synthesized evidence from eighteen randomized controlled trials comprising an aggregate population of 3,593 participants. Eligible investigations focused primarily on gay, bisexual, and other men who have sex with men, alongside transgender women engaged in oral prophylaxis regimens. The digital technologies analyzed across trials encompassed multiple modalities, including text messaging platforms, targeted mobile applications, electronic smart pillboxes, and dedicated interactive web resources.
Investigative protocols followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines across eight extensive literature databases, including PubMed, Web of Science, Embase, Scopus, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Library, the China National Knowledge Infrastructure, and ProQuest Dissertations & Theses Global. Clinical trials registries, including ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform, were systematically evaluated from inception through October 2026. Investigators analyzed study validity using the Cochrane risk-of-bias framework for randomized trials and evaluated certainty of evidence using the Grading of Recommendations, Assessment, Development and Evaluation approach.
Statistical pooling using random-effects modeling in R Statistical Software version 4.4.2 demonstrated measurable improvements in adherence during initial intervention windows. At 12 weeks of follow-up, participants receiving digital interventions exhibited a statistically significant improvement in oral pre-exposure prophylaxis adherence compared with controls, producing an estimated risk ratio of 1.12 with a 95% confidence interval ranging from 1.02 to 1.23. This adherence advantage persisted through intermediate observation intervals, yielding an estimated risk ratio of 1.14 with a 95% confidence interval spanning 1.02 to 1.28 at 24 weeks.
Despite positive results observed during the first 24 weeks, evidence supporting sustained adherence benefits beyond that timeframe proved insufficient. At time points exceeding 24 weeks, the calculated risk ratio reached 1.23 with a wide 95% confidence interval ranging from 0.84 to 1.81, crossing unity and reflecting statistical non-significance. This analytical attenuation highlights ongoing uncertainty regarding whether digitally mediated behavioral gains persist over prolonged prevention horizons.
Regarding oral pre-exposure prophylaxis initiation and use outcomes, digital interventions yielded varying impacts across study durations. At 12 weeks, digital tools did not produce a statistically significant increase in overall prophylaxis use, generating an estimated risk ratio of 1.66 accompanied by a wide confidence interval ranging from 0.34 to 7.96. By contrast, evaluations conducted at 24 weeks showed a statistically significant expansion in prophylaxis use, demonstrating a pooled risk ratio of 1.69 with a 95% confidence interval from 1.11 to 2.58.
Exploratory subgroup investigations suggested that multicomponent digital approaches might yield greater effectiveness than single-component strategies. However, because these evaluations relied strictly on between-study comparisons rather than direct within-trial head-to-head assessments, investigators noted that the patterns remain strictly exploratory and require formal experimental confirmation in future research.
The study authors concluded that while digital tools effectively strengthen prophylaxis compliance through 24 weeks among key populations, persistent intervention durability remains unproven. Future investigations must focus on establishing sustainable methodologies capable of reinforcing long-term participant retention and clarifying the precise clinical utility of complex, multicomponent digital delivery architectures.
Subject of Research: Effectiveness of digital interventions on oral HIV pre-exposure prophylaxis adherence and use
Article Title: Digital interventions for oral HIV PrEP adherence and use: a systematic review and meta-analysis
Article References: Yue, L.-F., Hou, J.-H., Zhu, Y.-Y., Gao, J., Chu, Z.-X., Meng, Y.-L., Jiang, Y.-J., Wu, Z.-H., & Hu, Q.-H. (2026). Digital interventions for oral HIV PrEP adherence and use: a systematic review and meta-analysis. BMC Public Health. https://doi.org/10.1186/s12889-026-30482-x
Image Credits: AI Generated
DOI: 10.1186/s12889-026-30482-x
Keywords: HIV prevention, pre-exposure prophylaxis, PrEP adherence, digital health, meta-analysis, systematic review, randomized controlled trials, text messaging interventions, mobile health applications, smart pillboxes, sexual health, public health, adherence monitoring, behavioral interventions, transgender women health, preventive medicine
News Source: Ophelia Keating. (November 21, 2026). Digital Interventions Boost Oral HIV PrEP Adherence Up to 24 Weeks. Scienmag.



